Q32 Bio

QTTB

Market cap $255M

QTTB Hedge Fund Activity: Q1 2026 in Review

54 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q1 2026, worth a combined $60.6M — up 127% from $26.7M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new QTTB positions and 8 closed out — a net gain of 4 holders — while 14 added to existing stakes and 9 trimmed.

The largest buyer was Opaleye Management, adding an estimated $4.95M. The largest seller was Acorn Capital Advisors, cutting an estimated $847K.

• 54 institutional investors held Q32 Bio (QTTB) as of Q1 2026, up from 52 in Q4 2025.
• Funds reported $60.6M of Q32 Bio stock for Q1 2026, up 127% quarter-over-quarter.
• 12 funds opened new Q32 Bio positions in Q1 2026 and 8 closed out, a net change of +4 holders.
• The largest Q32 Bio buyer in Q1 2026 was Opaleye Management, an estimated $4.95M added.
• The largest Q32 Bio seller in Q1 2026 was Acorn Capital Advisors, an estimated $847K sold.

Based on aggregated 13F filings for Q1 2026.